USAdvisors Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$331K Sell
286
-6,084
-96% -$7.18M 0.09% 112
2026
Q2
$367K Buy
+6,370
New +$6.51M 0.11% 105
2026
Q1
– Sell
-259
Closed -$279K – 141
2025
Q4
$279K Sell
259
-7
-3% -$6.69K 0.09% 109
2025
Q3
$203K Sell
266
-8
-3% -$5.95K 0.07% 128
2025
Q2
$213K Sell
274
-12
-4% -$9.32K 0.08% 121
2025
Q1
$236K Buy
286
+17
+6% +$14.1K 0.08% 116
2024
Q4
$208K Sell
269
-126
-32% -$104K 0.07% 130
2024
Q3
$347K Sell
395
-19
-5% -$17.1K 0.12% 93
2024
Q2
$375K Sell
414
-52
-11% -$41.6K 0.13% 88
2024
Q1
$363K Buy
466
+42
+10% +$29.9K 0.14% 99
2023
Q4
$247K Buy
+424
New +$247K 0.1% 113
2022
Q1
– Sell
-763
Closed -$211K – 135
2021
Q4
$211K Buy
+763
New +$193K 0.09% 119

Other funds holding LLY

USAdvisors Wealth Management's LLY Position: Q3 2026 in Review

USAdvisors Wealth Management reduced its Eli Lilly (LLY) stake by 96% in Q3 2026, selling an estimated $7.18M and leaving 286 shares worth $331K. The position accounts for 0.09% of the portfolio, ranked #112.

USAdvisors Wealth Management first reported a position in LLY in Q4 2021 and has held it in 12 quarters since. The position peaked at $375K in Q2 2024. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • USAdvisors Wealth Management held 286 shares of Eli Lilly worth $331K as of Q3 2026.
  • USAdvisors Wealth Management sold 6,084 Eli Lilly shares in Q3 2026, an estimated $7.18M.
  • Eli Lilly made up 0.09% of USAdvisors Wealth Management's portfolio in Q3 2026, its #112 holding.
  • USAdvisors Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 12 quarters since.
  • USAdvisors Wealth Management's Eli Lilly position peaked at $375K in Q2 2024.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on USAdvisors Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.